ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The role of upfront primary tumor resection in asymptomatic patients with unresectable stage IV colorectal cancer: A systematic review and meta-analysis

Liang, Zongyu; Liu, Zhiyuan; Huang, Chengzhi; Chen, Xin; Zhang, Zhaojun; Xiang, Meijuan; Hu, Weixian; Wang, Junjiang; Feng, Xingyu*; Yao, Xueqing*广东省人民医院; 南方医科大学; 汕头大学; 6
Frontiers in Surgery2023-1-6DOI: 10.3389/fsurg.2022.1047373
2被引6阅读
引用收藏
分享

摘要

BackgroundControversy exists over the role of upfront primary tumor resection (PTR) in asymptomatic patients with unresectable stage IV colorectal cancer (CRC). The purpose of this study was to evaluate the effect of upfront PTR on survival outcomes and adverse outcomes. MethodsSearches were conducted on PubMed, EMBASE, Web of Science, and Cochrane Library from inception to August 2021. Studies comparing survival outcomes with or without adverse outcomes between PTR and non-PTR treatments were included. Review Manager 5.3 was applied for meta-analyses with a random-effects model whenever possible. ResultsOverall, 20 studies with 3,088 patients were finally included in this systematic review. Compared with non-PTR, upfront PTR was associated with better 3-year (HR: 0.69, 95% CI, 0.57-0.83, P = 0.0001) and 5-year overall survival (OS) (HR: 0.77, 95% CI, 0.62-0.95, P = 0.01), while subgroup analysis indicated that there was no significant difference between upfront PTR and upfront chemotherapy (CT) group. In addition, grade 3 or higher adverse effects due to CT were more frequent in the PTR group with marginal significance (OR: 1.74, 95% CI, 0.99-3.06, P = 0.05), and other adverse outcomes were comparable. ConclusionsPTR might be related to improved OS for asymptomatic patients with unresectable stage IV CRC, whereas receiving upfront CT is a rational alternative without detrimental influence on survival or adverse outcomes compared with upfront PTR. Systematic Review Registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?RecordID=272675

学科与关键词

关键词
primary tumor resectioncolorectal cancerasymptomaticunresectableoverall survival
相关
加载中…
  • Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis
    Chen, Xianzhe; Hu, Weixian; Huang, Chengzhi; Liang, Weijun; Zhang, Jie; Wu, Deqing; Lv, Zejian; Li, Yong; Luo, Yuwen; Liang, Zongyu; Wang, Minjia; Wang, Junjiang; Yao, Xueqing*International Journal of Surgery, 2020, 80: 135-152.被引 10
  • Survival Benefit of Primary Tumor Resection Combined With Chemotherapy in Patients With Unresectable Colorectal Mucinous Adenocarcinoma With Liver Metastasis
    Liao, Shu-wen; Zhan, Jie-qun; Liu, Chu-tian; Yu, Hai-tao; Wen, Min-jie*American journal of clinical oncology : the official publication of the American Radium Society , 2024, 47(1): 30-39.
  • The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: A systematic review and meta-analysis
    Liang, Zongyu*; Li, Zhu; Yang, Qingshui; Feng, Jiahao; Xiang, Deyu; Lyu, Haina; Mai, Guangzhi; Wang, Wanchuan*Frontiers in Oncology, 2022, 12: 1024345.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Surgery
发表日期
2023-01-06
卷期
第 9 卷
页码
1047373
DOI
10.3389/fsurg.2022.1047373
成果收录
SCIE
资助标注
Science and Technology Planning Project of Guangdong Province, China [2017A030223006, 2016A020215128]; Science and Technology Planning Project of Guangzhou, China [201704020077]; Second Batch of Scientific Research Projects of Dengfeng Plan [DFJH201913]; Research Fund of Guangdong General Hospital [A2020019]; Yuexiu Science and Information Center of Guangzhou Scientific Foundation [202102080230]; Medical Scientific Research Foundation of Guangdong Province, China [Y-2019Roche-190]; Science and Technology Plan of Guangzhou, Guangdong Province, China [Y-HS2019/2-050]; Research Fund of CSCO-Roche Oncology; Research Fund of CSCO-Hansoh Oncology; [y012015338]; [2012-GX-046]

作者

  • L

    Liang, Zongyu (第一作者)

    2 · 6 · guangdong prov peoples hosp · shantou univ

  • L

    Liu, Zhiyuan

    guangdong prov peoples hosp · shantou univ

查看全部 10 位作者收起作者
  • H

    Huang, Chengzhi

    guangdong prov peoples hosp

  • C

    Chen, Xin

    guangdong prov peoples hosp · shantou univ

  • Z

    Zhang, Zhaojun

    guangdong prov peoples hosp

  • X

    Xiang, Meijuan

    guangdong prov peoples hosp

  • H

    Hu, Weixian

    guangdong prov peoples hosp

  • W

    Wang, Junjiang

    2 · southern med univ · guangdong prov peoples hosp · shantou univ

  • F

    Feng, Xingyu (通讯)

    guangdong prov peoples hosp

  • Y

    Yao, Xueqing (通讯)

    guangdong prov peoples hosp · shantou univ · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417